|
US1724052A
(en)
|
1928-06-13 |
1929-08-13 |
Luther S Swearengin |
Fire-door construction
|
|
US5034506A
(en)
|
1985-03-15 |
1991-07-23 |
Anti-Gene Development Group |
Uncharged morpholino-based polymers having achiral intersubunit linkages
|
|
US5283058A
(en)
|
1990-08-30 |
1994-02-01 |
The General Hospital Corporation |
Methods for inhibiting rejection of transplanted tissue
|
|
JPH06502577A
(ja)
|
1991-07-30 |
1994-03-24 |
バクスター、インターナショナル、インコーポレイテッド |
有孔埋め込み物
|
|
US7101543B2
(en)
|
2000-03-31 |
2006-09-05 |
Novarx |
Genetically modified cells expressing a TGFβ inhibitor, the cells being lung cancer cells
|
|
CA2406743A1
(en)
|
2000-04-28 |
2001-11-08 |
The Trustees Of The University Of Pennsylvania |
Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids
|
|
US20060222633A1
(en)
|
2000-05-11 |
2006-10-05 |
Yale University |
Prevention, decrease, and/or treatment of immunoreactivity by depleting and/or inactivating antigen presenting cells in the host
|
|
US6635750B1
(en)
|
2000-07-20 |
2003-10-21 |
Millennium Pharmaceuticals, Inc. |
B7-H2 nucleic acids, members of the B7 family
|
|
WO2003014313A2
(en)
|
2001-08-06 |
2003-02-20 |
Bresagen, Ltd. |
Alternative compositions and methods for the culture of stem cells
|
|
US7985585B2
(en)
|
2004-07-09 |
2011-07-26 |
Viacyte, Inc. |
Preprimitive streak and mesendoderm cells
|
|
US7541185B2
(en)
|
2003-12-23 |
2009-06-02 |
Cythera, Inc. |
Methods for identifying factors for differentiating definitive endoderm
|
|
WO2007059007A2
(en)
|
2005-11-14 |
2007-05-24 |
Cythera, Inc. |
Markers of definitive endoderm
|
|
US20050266554A1
(en)
|
2004-04-27 |
2005-12-01 |
D Amour Kevin A |
PDX1 expressing endoderm
|
|
CN103898047B
(zh)
|
2003-12-23 |
2020-03-03 |
维亚希特公司 |
定形内胚层
|
|
EP1791952A4
(en)
|
2004-08-13 |
2008-06-11 |
Univ Georgia Res Found |
COMPOSITIONS AND METHODS OF SELF-RENEWAL AND DIFFERENTIATION IN HUMAN EMBRYONAL STEM CELLS
|
|
EP1856526A4
(en)
|
2005-01-20 |
2008-11-12 |
Univ Rochester |
THIOREDOXIN-INTERACTING PROTEIN (TXNIP) AS REGULATOR OF VASCULAR FUNCTION
|
|
AU2006305879B2
(en)
|
2005-10-27 |
2012-05-10 |
Viacyte, Inc. |
PDX1-expressing dorsal and ventral foregut endoderm
|
|
KR20080109775A
(ko)
|
2006-02-23 |
2008-12-17 |
노보셀, 인크 |
분화가능한 세포를 배양하는데 유용한 조성물 및 방법
|
|
US7695965B2
(en)
|
2006-03-02 |
2010-04-13 |
Cythera, Inc. |
Methods of producing pancreatic hormones
|
|
EP1999253B1
(en)
|
2006-03-02 |
2019-05-22 |
Viacyte, Inc. |
Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production
|
|
WO2007139929A2
(en)
|
2006-05-25 |
2007-12-06 |
The Burnham Institute For Medical Research |
Methods for culture and production of single cell populations of human embryonic stem cells
|
|
CA3114827C
(en)
|
2007-07-31 |
2023-09-05 |
Lifescan, Inc. |
Differentiation of human embryonic stem cells to pancreatic endocrine
|
|
US7695963B2
(en)
|
2007-09-24 |
2010-04-13 |
Cythera, Inc. |
Methods for increasing definitive endoderm production
|
|
US8623650B2
(en)
|
2007-10-19 |
2014-01-07 |
Viacyte, Inc. |
Methods and compositions for feeder-free pluripotent stem cell media containing human serum
|
|
EP2229434B1
(en)
|
2007-11-27 |
2011-09-07 |
Lifescan, Inc. |
Differentiation of human embryonic stem cells
|
|
US8338170B2
(en)
|
2008-04-21 |
2012-12-25 |
Viacyte, Inc. |
Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells
|
|
US7939322B2
(en)
|
2008-04-24 |
2011-05-10 |
Centocor Ortho Biotech Inc. |
Cells expressing pluripotency markers and expressing markers characteristic of the definitive endoderm
|
|
US20120058105A1
(en)
|
2008-06-27 |
2012-03-08 |
Martin Kean Chong Ng |
Method of treatment of vascular complications
|
|
PL2346988T3
(pl)
|
2008-10-31 |
2017-10-31 |
Janssen Biotech Inc |
Różnicowanie ludzkich zarodkowych komórek macierzystych do linii endokrynnej trzustki
|
|
MX349178B
(es)
|
2008-10-31 |
2017-07-17 |
Centocor Ortho Biotech Inc |
Diferenciación de células madre embrionarias humanas al linaje endocrino pancreático.
|
|
US8008075B2
(en)
|
2008-11-04 |
2011-08-30 |
Viacyte, Inc. |
Stem cell aggregate suspension compositions and methods of differentiation thereof
|
|
US8895300B2
(en)
|
2008-11-04 |
2014-11-25 |
Viacyte, Inc. |
Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof
|
|
AU2009313870B2
(en)
|
2008-11-14 |
2013-07-11 |
Viacyte, Inc. |
Encapsulation of pancreatic cells derived from human pluripotent stem cells
|
|
US20100272710A1
(en)
|
2009-03-26 |
2010-10-28 |
Abdelhadi Rebbaa |
Compositions and methods for treating and preventing aging-associated diseases
|
|
US20100272695A1
(en)
|
2009-04-22 |
2010-10-28 |
Alan Agulnick |
Cell compositions derived from dedifferentiated reprogrammed cells
|
|
US9109245B2
(en)
|
2009-04-22 |
2015-08-18 |
Viacyte, Inc. |
Cell compositions derived from dedifferentiated reprogrammed cells
|
|
US8685726B2
(en)
|
2009-04-27 |
2014-04-01 |
Viacyte, Inc. |
Small molecules supporting pluripotent cell growth and methods thereof
|
|
SG177483A1
(en)
|
2009-07-20 |
2012-02-28 |
Janssen Biotech Inc |
Differentiation of human embryonic stem cells
|
|
EP2456859A4
(en)
|
2009-07-20 |
2015-03-18 |
Janssen Biotech Inc |
DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS
|
|
CA2784425A1
(en)
|
2009-12-23 |
2011-06-30 |
Centocor Ortho Biotech Inc. |
Differentiation of human embryonic stem cells
|
|
SG181687A1
(en)
|
2009-12-23 |
2012-07-30 |
Centocor Ortho Biotech Inc |
Differentiation of human embryonic stem cells
|
|
ES2658146T3
(es)
|
2010-08-31 |
2018-03-08 |
Janssen Biotech, Inc. |
Diferenciación de células madre embrionarias humanas
|
|
EP2611907B1
(en)
|
2010-08-31 |
2016-05-04 |
Janssen Biotech, Inc. |
Differentiation of pluripotent stem cells
|
|
AU2010365057B2
(en)
|
2010-12-08 |
2016-12-22 |
Viacyte, Inc. |
Agents and methods for inhibiting human pluripotent stem cell growth
|
|
WO2012145384A1
(en)
|
2011-04-20 |
2012-10-26 |
University Of Washington Through Its Center For Commercialization |
Beta-2 microglobulin-deficient cells
|
|
USD728095S1
(en)
|
2011-12-12 |
2015-04-28 |
Viacyte, Inc. |
Cell encapsulation device
|
|
USD726307S1
(en)
|
2011-12-12 |
2015-04-07 |
Viacyte Inc. |
Cell encapsulation device
|
|
USD726306S1
(en)
|
2011-12-12 |
2015-04-07 |
Viacyte, Inc. |
Cell encapsulation device
|
|
CN104114572A
(zh)
|
2011-12-16 |
2014-10-22 |
现代治疗公司 |
经修饰的核苷、核苷酸和核酸组合物
|
|
KR102203056B1
(ko)
|
2011-12-22 |
2021-01-14 |
얀센 바이오테크 인코포레이티드 |
인간 배아 줄기 세포의 단일 인슐린 호르몬 양성 세포로의 분화
|
|
ES2615346T3
(es)
|
2012-04-25 |
2017-06-06 |
Deutsches Krebsforschungszentrum |
Inhibidores de la proteína que interacciona con tiorredoxina (TXNIP) para terapia
|
|
JP6450674B2
(ja)
|
2012-05-07 |
2019-01-09 |
ヤンセン バイオテツク，インコーポレーテツド |
ヒト胚性幹細胞の膵臓の内胚葉への分化
|
|
EP3241902B1
(en)
|
2012-05-25 |
2018-02-28 |
The Regents of The University of California |
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
|
|
USD734847S1
(en)
|
2012-05-31 |
2015-07-21 |
Viacyte, Inc. |
Cell encapsulation device
|
|
AU2013271581B2
(en)
|
2012-06-08 |
2018-08-09 |
Janssen Biotech, Inc. |
Differentiation of human embryonic stem cells into pancreatic endocrine cells
|
|
EP2861723A4
(en)
|
2012-06-14 |
2016-01-20 |
Janssen Biotech Inc |
DIFFERENTIATION OF HUMAN EMBRYONAL STEM CELLS IN ENDOCRINE PANCREAS CELLS
|
|
CN105121648B
(zh)
|
2012-12-12 |
2021-05-07 |
布罗德研究所有限公司 |
用于序列操纵的系统、方法和优化的指导组合物的工程化
|
|
RU2687379C2
(ru)
|
2012-12-31 |
2019-05-13 |
Янссен Байотек, Инк. |
Суспендирование и кластеризация плюрипотентных клеток человека с целью их дифференцировки в панкреатические эндокринные клетки
|
|
BR112015015770A2
(pt)
|
2012-12-31 |
2017-07-11 |
Janssen Biotech Inc |
cultivo de células-tronco embrionárias humanas na interface ar-líquido para diferenciação em células pancreáticas endócrinas
|
|
US10370644B2
(en)
|
2012-12-31 |
2019-08-06 |
Janssen Biotech, Inc. |
Method for making human pluripotent suspension cultures and cells derived therefrom
|
|
JP6557147B2
(ja)
|
2012-12-31 |
2019-08-07 |
ヤンセン バイオテツク，インコーポレーテツド |
Ｈｂ９調節物を用いたヒト胚性幹細胞の膵臓内分泌細胞への分化
|
|
USD720469S1
(en)
|
2013-03-07 |
2014-12-30 |
Viacyte, Inc. |
Cell encapsulation device
|
|
JP6234485B2
(ja)
|
2013-03-07 |
2017-11-22 |
ヴィアサイト インコーポレイテッド |
３次元大収容力細胞封入デバイスアセンブリー
|
|
US8859286B2
(en)
|
2013-03-14 |
2014-10-14 |
Viacyte, Inc. |
In vitro differentiation of pluripotent stem cells to pancreatic endoderm cells (PEC) and endocrine cells
|
|
US9101597B2
(en)
|
2013-03-14 |
2015-08-11 |
The Administration Of The Tulane Educational Fund |
Immunoprotective primary mesenchymal stem cells and methods
|
|
BR112015030211A2
(pt)
|
2013-06-03 |
2017-08-22 |
Theravectys |
Vetores lentivirais contendo uma sequência promotora a montante da mhc de classe i, mhc de classe ii ou microglobulina beta-2
|
|
SG11201510177WA
(en)
|
2013-06-11 |
2016-01-28 |
Harvard College |
SC-β CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME
|
|
KR20140144964A
(ko)
|
2013-06-12 |
2014-12-22 |
한국생명공학연구원 |
티오레독신-결합 단백질을 유효성분으로 포함하는 약학적 조성물 및 이의 용도
|
|
KR20250012194A
(ko)
|
2013-06-17 |
2025-01-23 |
더 브로드 인스티튜트, 인코퍼레이티드 |
바이러스 구성성분을 사용하여 장애 및 질환을 표적화하기 위한 crispr-cas 시스템 및 조성물의 전달, 용도 및 치료 적용
|
|
KR20160079072A
(ko)
|
2013-11-01 |
2016-07-05 |
얀센 바이오테크 인코포레이티드 |
췌장 내분비 세포로의 분화를 위한 인간 만능 줄기세포의 현탁 및 클러스터링
|
|
USD718467S1
(en)
|
2014-03-07 |
2014-11-25 |
Viacyte, Inc. |
3-dimensional large capacity cell encapsulation device
|
|
USD718471S1
(en)
|
2014-03-07 |
2014-11-25 |
Viacyte, Inc. |
3-dimensional large capacity cell encapsulation device
|
|
USD718470S1
(en)
|
2014-03-07 |
2014-11-25 |
Viacyte, Inc. |
3-dimensional large capacity cell encapsulation device
|
|
USD714956S1
(en)
|
2014-03-07 |
2014-10-07 |
Viacyte, Inc. |
3-dimensional large capacity cell encapsulation device
|
|
USD718468S1
(en)
|
2014-03-07 |
2014-11-25 |
Viacyte, Inc. |
3-dimensional large capacity cell encapsulation device
|
|
USD718466S1
(en)
|
2014-03-07 |
2014-11-25 |
Viacyte, Inc. |
3-Dimensional large capacity cell encapsulation device
|
|
USD718469S1
(en)
|
2014-03-07 |
2014-11-25 |
Viacyte, Inc. |
3-dimensional large capacity cell encapsulation device
|
|
USD718472S1
(en)
|
2014-03-07 |
2014-11-25 |
Viacyte, Inc. |
3-dimensional large capacity cell encapsulation device
|
|
MX373460B
(es)
|
2014-03-11 |
2020-04-07 |
Cellectis |
Metodo para generar celulas t compatibles para el trasplante alogenico.
|
|
EP3122370A1
(en)
*
|
2014-03-28 |
2017-02-01 |
Buck Institute for Research on Aging |
Methods and compositions for modulating the immune system
|
|
USD761423S1
(en)
|
2014-04-16 |
2016-07-12 |
Viacyte, Inc. |
Sizing tool for an encapsulation device
|
|
USD761424S1
(en)
|
2014-04-16 |
2016-07-12 |
Viacyte, Inc. |
Deployment tool for an encapsulation device
|
|
USD760399S1
(en)
|
2014-04-16 |
2016-06-28 |
Viacyte, Inc. |
Case for an encapsulation device
|
|
USD734166S1
(en)
|
2014-04-16 |
2015-07-14 |
Viacyte, Inc. |
Fill pouch assembly for encapsulation device
|
|
US10006006B2
(en)
|
2014-05-16 |
2018-06-26 |
Janssen Biotech, Inc. |
Use of small molecules to enhance MAFA expression in pancreatic endocrine cells
|
|
WO2016073955A2
(en)
|
2014-11-06 |
2016-05-12 |
President And Fellows Of Harvard College |
Cells lacking b2m surface expression and methods for allogeneic administration of such cells
|
|
AU2015363008B2
(en)
|
2014-12-19 |
2021-12-09 |
Janssen Biotech, Inc. |
Suspension culturing of pluripotent stem cells
|
|
EP3294342A4
(en)
|
2015-05-08 |
2018-11-07 |
President and Fellows of Harvard College |
Universal donor stem cells and related methods
|
|
GB2592821B
(en)
|
2015-07-31 |
2022-01-12 |
Univ Minnesota |
Modified cells and methods of therapy
|
|
JP6928604B2
(ja)
*
|
2015-11-04 |
2021-09-01 |
フェイト セラピューティクス，インコーポレイテッド |
万能性細胞のゲノム改変
|
|
WO2017222879A1
(en)
|
2016-06-21 |
2017-12-28 |
Janssen Biotech, Inc. |
Generation of human pluripotent stem cell derived functional beta cells showing a glucose-dependent mitochondrial respiration and two-phase insulin secretion response
|
|
CN110312799A
(zh)
|
2016-08-17 |
2019-10-08 |
博德研究所 |
新型crispr酶和系统
|
|
US9982267B2
(en)
|
2016-10-12 |
2018-05-29 |
Feldan Bio Inc. |
Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same
|
|
DK3537986T3
(da)
|
2016-11-10 |
2025-07-21 |
Viacyte Inc |
Pdx1 pankreatiske endodermceller i celleleveringsanordning
|
|
CN110177869A
(zh)
|
2017-01-13 |
2019-08-27 |
加利福尼亚大学董事会 |
免疫改造的多能细胞
|
|
EP3596117A4
(en)
|
2017-03-17 |
2021-01-13 |
The Johns Hopkins University |
TARGETED EPIGENETIC THERAPY AGAINST THE DISTAL EXPRESSION REGULATORY ELEMENT OF TGFB2
|
|
CN120041380A
(zh)
|
2017-06-12 |
2025-05-27 |
西奈卫生系统公司 |
无需全身性免疫遏制的同种异体移植物耐受
|
|
US10391156B2
(en)
|
2017-07-12 |
2019-08-27 |
Viacyte, Inc. |
University donor cells and related methods
|
|
KR20200075851A
(ko)
|
2017-10-19 |
2020-06-26 |
셀렉티스 |
개선된 면역 세포들 치료를 위한 nk 억제제들의 타겟인 유전자 통합
|
|
CN107723275B
(zh)
|
2017-10-20 |
2020-09-04 |
重庆精准生物技术有限公司 |
通用型car-t细胞及其制备方法和应用
|
|
US20200407713A1
(en)
|
2017-11-16 |
2020-12-31 |
Mogam Institute For Biomedical Research |
Transformed human cell and use thereof
|
|
US20210015859A1
(en)
|
2017-12-08 |
2021-01-21 |
Fate Therapeutics, Inc. |
IMMUNOTHERAPIES USING ENHANCED iPSC DERIVED EFFECTOR CELLS
|
|
US20190223416A1
(en)
|
2018-01-23 |
2019-07-25 |
Cotyledon, LLC |
Canine genome editing
|
|
EP3754018A4
(en)
|
2018-02-16 |
2021-11-24 |
Kyoto University |
LOW ANTIGENIC CELL PRODUCTION PROCESS
|
|
US12378572B2
(en)
|
2018-09-07 |
2025-08-05 |
Crispr Therapeutics Ag |
Universal donor cells
|
|
AU2019387218A1
(en)
|
2018-11-26 |
2021-06-03 |
Massachusetts Institute Of Technology |
Compositions and methods for immune tolerance
|
|
CA3123102A1
(en)
|
2018-12-13 |
2020-06-18 |
Sinai Health System |
Immunomodulatory cells and uses thereof
|
|
WO2020206055A1
(en)
|
2019-04-02 |
2020-10-08 |
Yale University |
Methods of treatment of diseases and disorders associated with increased tet level, increased h19 level, increased level of tgf signaling, or any combination thereof
|
|
WO2020231882A2
(en)
*
|
2019-05-10 |
2020-11-19 |
The Regents Of The University Of California |
Modified pluripotent cells
|
|
WO2020228039A1
(en)
|
2019-05-16 |
2020-11-19 |
Egenesis, Inc. |
Cells, tissues, organs, and/or animals having one or more modified genes for enhanced xenograft survival and/or tolerance
|
|
CN110373389A
(zh)
*
|
2019-06-10 |
2019-10-25 |
云南农业大学 |
一种适合胰岛细胞及皮肤等组织异种移植供体猪的构建方法
|
|
KR20220058579A
(ko)
*
|
2019-09-05 |
2022-05-09 |
크리스퍼 테라퓨틱스 아게 |
보편적 공여자 세포
|
|
US11104918B2
(en)
|
2019-09-05 |
2021-08-31 |
Crispr Therapeutics Ag |
Universal donor cells
|
|
KR20230146007A
(ko)
|
2020-12-31 |
2023-10-18 |
크리스퍼 테라퓨틱스 아게 |
범용 공여자 세포
|